Paluszkiewicz Lech, Morshuis Michiel, Hakim-Meibodi Kavous, Ensminger Stephan, Gummert Jan
Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany.
Kardiochir Torakochirurgia Pol. 2014 Dec;11(4):428-31. doi: 10.5114/kitp.2014.47346. Epub 2014 Nov 30.
Here we present a patient after implantation of a left ventricular assist device (HeartWare) for destination therapy complicated by recurrent thrombosis of the device. At 14 months after implantation, the patient presented with a pump thrombosis after an INR incompliance period. A surgical pump exchange was performed and the patient recovered uneventfully. Five months later a pump thrombosis occurred again, and the patient refused surgery. Systemic thrombolysis was carried out this time. Three and 6 months later the same clinical picture was presented again, and repeat thrombolysis was performed successfully. The patient was discharged and has remained stable since, without any symptoms of thrombosis of the device.
在此,我们介绍一位接受左心室辅助装置(HeartWare)植入以进行终末期治疗的患者,该患者出现了装置反复血栓形成的并发症。植入后14个月,患者在国际标准化比值(INR)未达标的一段时间后出现了泵血栓形成。进行了手术泵置换,患者恢复顺利。五个月后再次发生泵血栓形成,患者拒绝手术。此次进行了全身溶栓治疗。三个月和六个月后,同样的临床表现再次出现,再次成功进行了溶栓治疗。患者出院,此后一直保持稳定,未出现装置血栓形成的任何症状。